|
Research & Development
|
38.44M | 18.94M |
|
Selling, General & Administrative
|
13.00M | 15.33M |
|
Other Operating Expenses
|
| 35.00M |
|
Operating Expenses
|
51.44M | 34.27M |
|
Operating Income
|
-51.44M | 0.73M |
|
EBIT
|
-51.44M | 0.73M |
|
Interest & Investment Income
|
0.23M | 0.94M |
|
Other Non Operating Income
|
-0.17M | -0.10M |
|
Non Operating Income
|
-0.17M | 0.85M |
|
EBT
|
-51.38M | 1.58M |
|
Tax Provisions
|
| 0.09M |
|
Profit After Tax
|
-51.38M | 1.49M |
|
Income from Continuing Operations
|
-51.38M | 1.49M |
|
Consolidated Net Income
|
-51.38M | 1.49M |
|
Income towards Parent Company
|
-51.38M | 1.49M |
|
Net Income towards Common Stockholders
|
-51.38M | 1.49M |
|
EPS (Basic)
|
-2.37 | 0.06 |
|
EPS (Weighted Average and Diluted)
|
-2.37 | 0.06 |
|
Shares Outstanding (Weighted Average)
|
6.57M | 6.57M |
|
EBITDA
|
-51.40M | 1.50M |
|
Tax Rate
|
| 5.58% |